Lei-Jie Dai

机构：Shanghai Medical College of Fudan University, Fudan University Shanghai Cancer Center · ORCID：0000-0002-8539-8921

发表论文 49 篇 · 总被引 1079 次 · h-index 9

代表论文

Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer (2025 · Cancer Cell · 被引 52)
Omics datasets can bridge the gap between tumor biology and patient care (2025 · PLoS Biology · 被引 2)
Spatially interpretable artificial intelligence framework to tailored neoadjuvant dual HER2 blockade in HER2-positive breast cancer (2026 · Signal Transduction and Targeted Therapy)
Table S2 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies (2026)
Figure S6 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies (2026)
Figure S4 from Molecular Characterization and Classification of HER2-Positive Breast Cancer Inform Tailored Therapeutic Strategies (2026)